Citigroup
QUIT icon

Citigroup’s Achieve Life Sciences QUIT Stock Holding History

Citigroup’s Portfolio QUIT Stock Details QUIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$328K Sell
40,578
-33,536
-45% -$240K ﹤0.01% 3984
2026
Q2 		$484K Buy
74,114
+68,666
+1,260% +$327K ﹤0.01% 3915
2026
Q1 		$16K Sell
5,448
-27,520
-83% -$122K ﹤0.01% 4891
2025
Q4 		$164K Buy
+32,968
New +$144K ﹤0.01% 4085
2025
Q2 		– Sell
-24,252
Closed -$64.8K – 5625
2025
Q1 		$64.8K Sell
24,252
-22,841
-49% -$71K ﹤0.01% 4802
2024
Q4 		$166K Buy
47,093
+22,157
+89% +$100K ﹤0.01% 4527
2024
Q3 		$118K Buy
24,936
+17,349
+229% +$79.3K ﹤0.01% 4692
2024
Q2 		$35.7K Buy
+7,587
New +$36.6K ﹤0.01% 4778
2018
Q3 		– Sell
-1
Closed – – 7720
2018
Q2 		$0 Buy
+1
New +$204 ﹤0.01% 7584
2018
Q1 		– Sell
-4
Closed -$1K – 7516
2017
Q4 		$1K Hold
4
– – ﹤0.01% 7453
2017
Q3 		$2K Hold
4
– – ﹤0.01% 7005
2017
Q2 		$4K Sell
4
-1
-20% -$811 ﹤0.01% 6780
2017
Q1 		$4K Hold
5
– – ﹤0.01% 6842
2016
Q4 		$5K Hold
5
– – ﹤0.01% 6904
2016
Q3 		$5K Hold
5
– – ﹤0.01% 6752
2016
Q2 		$11K Hold
5
– – ﹤0.01% 6480
2016
Q1 		$7K Hold
5
– – ﹤0.01% 6892
2015
Q4 		$13K Hold
5
– – ﹤0.01% 6679
2015
Q3 		$23K Hold
5
– – ﹤0.01% 5928
2015
Q2 		$24K Hold
5
– – ﹤0.01% 5991
2015
Q1 		$22K Hold
5
– – ﹤0.01% 6044
2014
Q4 		$24K Hold
5
– – ﹤0.01% 6119
2014
Q3 		$31K Sell
5
-1
-17% -$6.95K ﹤0.01% 5615
2014
Q2 		$50K Hold
6
– – ﹤0.01% 5167
2014
Q1 		$149K Sell
6
-1
-14% -$24.6K ﹤0.01% 4625
2013
Q4 		$120K Buy
7
+3
+75% +$52.6K ﹤0.01% 5107
2013
Q3 		$91K Hold
4
– – ﹤0.01% 4805
2013
Q2 		$96K Buy
+4
New +$89.5K ﹤0.01% 4889

Other funds holding QUIT

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return

Citigroup's QUIT Position: Q3 2026 in Review

Citigroup reduced its Achieve Life Sciences (QUIT) stake by 45% in Q3 2026, selling an estimated $240K and leaving 40,578 shares worth $328K. The position accounts for ﹤0.01% of the portfolio, ranked #3984.

Citigroup first reported a position in QUIT in Q2 2013 and has held it in 28 quarters since. The position peaked at $484K in Q2 2026. 42 funds tracked by Wall St. Rank hold QUIT as of Q3 2026.

  • Citigroup held 40,578 shares of Achieve Life Sciences worth $328K as of Q3 2026.
  • Citigroup sold 33,536 Achieve Life Sciences shares in Q3 2026, an estimated $240K.
  • Achieve Life Sciences made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #3984 holding.
  • Citigroup first reported a position in Achieve Life Sciences in Q2 2013 and has held it in 28 quarters since.
  • Citigroup's Achieve Life Sciences position peaked at $484K in Q2 2026.
  • 42 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.